Neuromonics Limited – Trademark Portfolio
Entity Type: 03
Neuromonics Limited holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NEUROMONICS. The owner is based in Chatswood, New South Wales.
Units 10-11
56 Neridah Street
Chatswood, New South Wales 2067 , AU
Showing of trademarks Trademarks
Trademark Classifications
Neuromonics Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Neuromonics Limited have?
Neuromonics Limited has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Neuromonics Limited file in?
Neuromonics Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Neuromonics Limited's most well-known trademarks?
Neuromonics Limited's registered trademark portfolio includes well-known marks such as NEUROMONICS. These are among 1 currently registered trademark in the portfolio.
What is Neuromonics Limited's trademark registration success rate?
Neuromonics Limited has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.